Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading activity on Wednesday. Traders purchased 1,885 put options on the stock. Thisrepresentsanincreaseofapproximately1,101% compared to the average volume of 157 put options.

Evelo Biosciences Stock Performance

NASDAQ EVLO opened at $0.00 on Friday. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $0.02.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.